In vitro studies on anti-obesity activity of Korean Memilmuk through AMPK activation

Insights

Buckwheat flour extract from Korean Memilmuk inhibits fat cell differentiation and lipid accumulation. This anti-obesity effect may involve regulating key proteins like peroxisome proliferator-activated receptor γ and AMP-activated protein kinase.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Nutrition Science

Background:

  • Obesity is a growing global health concern requiring novel therapeutic strategies.
  • Korean traditional foods, like Memilmuk made from buckwheat, are potential sources of bioactive compounds.
  • Understanding the molecular mechanisms behind the anti-obesity effects of such foods is crucial.

Purpose of the Study:

  • To investigate the anti-obesity potential of buckwheat flour extract, a key component of Memilmuk.
  • To determine the effect of buckwheat flour extract on the differentiation of preadipocytes (3T3-L1 cells).
  • To elucidate the molecular pathways involved in the anti-obesity action of buckwheat flour extract.

Main Methods:

  • Utilized 3T3-L1 preadipocytes to model fat cell development.
  • Employed Oil-Red O staining to quantify lipid accumulation.
  • Assessed the expression levels of adipogenic transcription factors, including peroxisome proliferator-activated receptor γ (PPARγ) and AMP-activated protein kinase (AMPK).

Main Results:

  • Buckwheat flour extract significantly reduced lipid accumulation in differentiated adipocytes.
  • The extract demonstrated an inhibitory effect on adipocyte differentiation.
  • Buckwheat flour extract suppressed the expression of PPARγ and modulated AMPK activity.

Conclusions:

  • Buckwheat flour extract exhibits anti-obesity properties by inhibiting adipocyte differentiation.
  • The anti-obesity mechanism may involve the down-regulation of PPARγ expression.
  • AMP-activated protein kinase (AMPK) activation by buckwheat flour extract appears to play a role in mediating these effects.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
279